Banco Bilbao Vizcaya Argentaria S.A. increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 5.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,667 shares of the company's stock after acquiring an additional 1,454 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in HCA Healthcare were worth $10,598,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also bought and sold shares of HCA. Cheviot Value Management LLC bought a new position in HCA Healthcare during the 1st quarter worth approximately $26,000. Atwood & Palmer Inc. bought a new position in HCA Healthcare during the 1st quarter worth approximately $28,000. Bartlett & CO. Wealth Management LLC lifted its holdings in HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after buying an additional 80 shares during the period. ORG Partners LLC lifted its holdings in HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after buying an additional 86 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its holdings in HCA Healthcare by 75.8% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after buying an additional 50 shares during the period. 62.73% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on HCA shares. Truist Financial boosted their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research report on Wednesday, July 16th. Barclays reduced their price objective on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research report on Monday, July 28th. Robert W. Baird lifted their price target on HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research report on Thursday, August 14th. Stephens upgraded HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Finally, Bank of America lowered HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price target on the stock. in a research report on Wednesday, July 16th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company's stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and an average target price of $398.58.
Get Our Latest Analysis on HCA Healthcare
HCA Healthcare Stock Up 0.2%
NYSE:HCA traded up $0.61 during trading hours on Friday, reaching $404.87. 1,081,188 shares of the company traded hands, compared to its average volume of 1,431,386. The business's 50-day moving average price is $373.91 and its two-hundred day moving average price is $354.02. The stock has a market capitalization of $94.74 billion, a P/E ratio of 17.02, a P/E/G ratio of 1.27 and a beta of 1.39. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Recommended Stories

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.